Foreign investors continue to sell Indian shares. November saw outflows of Rs 3,788 crore. This follows significant selling throughout 2025. Experts note improved sentiment but tentative flows. Valuations and earnings clarity are key concerns. Investors await earnings growth to catch up before increasing exposure. Year-end portfolio rebalancing will offer clues.
Corona Remedies and Wakefit Innovations to list tomorrow; GMP suggests sharp upside for pharma play
Corona Remedies and Wakefit Innovations are set to list amid divergent grey market signals. Corona Remedies commands strong listing expectations backed by robust subscriptions and